Fig. 11
From: Establishment and characterisation of a novel canine mast cell tumour cell line (C18)
Cytotoxicity of healthy donor PBMCs against canine MCT cell lines. Each row represents the percentages of viable, early apoptotic, late apoptotic and total apoptotic MCT cells of each cell line (*p < 0.05, **p < 0.01, ***p < 0.001)